- Home
- PCRX vs PDM Comparison
PCRX vs PDM Comparison
Compare PCRX & PDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- PDM
- Stock Information
- Founded
- PCRX 2006
- PDM 1997
- Country
- PCRX United States
- PDM United States
- Employees
- PCRX N/A
- PDM N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- PDM Building operators
- Sector
- PCRX Health Care
- PDM Real Estate
- Exchange
- PCRX Nasdaq
- PDM Nasdaq
- Market Cap
- PCRX 1.2B
- PDM 1.1B
- IPO Year
- PCRX 2011
- PDM N/A
- Fundamental
- Price
- PCRX $23.63
- PDM $8.59
- Analyst Decision
- PCRX Buy
- PDM Buy
- Analyst Count
- PCRX 5
- PDM 5
- Target Price
- PCRX $32.40
- PDM $9.40
- AVG Volume (30 Days)
- PCRX 532.5K
- PDM 864.9K
- Earning Date
- PCRX 11-05-2025
- PDM 10-23-2025
- Dividend Yield
- PCRX N/A
- PDM 2.90%
- EPS Growth
- PCRX N/A
- PDM N/A
- EPS
- PCRX N/A
- PDM N/A
- Revenue
- PCRX $705,848,000.00
- PDM $565,502,000.00
- Revenue This Year
- PCRX $7.36
- PDM $0.09
- Revenue Next Year
- PCRX $10.07
- PDM N/A
- P/E Ratio
- PCRX N/A
- PDM N/A
- Revenue Growth
- PCRX 2.25
- PDM N/A
- 52 Week Low
- PCRX $15.16
- PDM $5.46
- 52 Week High
- PCRX $27.64
- PDM $11.12
- Technical
- Relative Strength Index (RSI)
- PCRX 32.49
- PDM 49.43
- Support Level
- PCRX $24.31
- PDM $8.67
- Resistance Level
- PCRX $26.05
- PDM $9.03
- Average True Range (ATR)
- PCRX 0.76
- PDM 0.21
- MACD
- PCRX -0.33
- PDM -0.07
- Stochastic Oscillator
- PCRX 6.34
- PDM 0.00
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About PDM Piedmont Office Realty Trust Inc.
Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across major U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.